Astellas makes leadership appointments
Catherine Levitt has been named EVP and general counsel, leading Astellas newly restructured legal unit, Steve Sabus will lead the medical specialties business unit as SVP and Lynn Fenicchia was named VP and lead the new commercial strategy and operations unit.
Prime Therapeutics hires specialty pharmacy SVP
Kyle Skiermont has joined Prime as SVP of specialty pharmacy and home delivery services. Previously, Skiermont was COO for Fairview Pharmacy Services in Minneapolis and St. Paul.
Chiasma appoints commercial chief
Anand Varadan has been appointed EVP and chief commercial officer at Chiasma. Varadan previously held this role at Chiasma before becoming a strategic advisor to the company. He also previously served as chief commercial officer of Karyopharm Therapeutics.
Capital Rx names commercial markets president
Matthew Gibbs was named president of commercial markets at Capital Rx, a New York-based pharmacy benefit manager. Gibbs joins the company from Aon, where he served as SVP.
Personal Genome Diagnostics appoints CEO
Megan Bailey has been promoted to CEO of Baltimore-based Personal Genome Diagnostics. She was previously chief commercial officer at the company.
ADC Therapeutics hires financial chief
Jennifer Creel has joined ADC Therapeutics as chief financial officer. Previously, Creel served in financial roles at Celgene for 11 years.
Zogenix appoints general counsel
Shawnte M. Mitchell has been named EVP, general counsel and secretary at the rare disease pharma company Zogenix. She previously served as general counsel and corporate affairs SVP at Aptevo Therapeutics.
The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Carrie Gavit at firstname.lastname@example.org.